Abstract
Liver transplantation (LT) recipients exhibit heightened susceptibility to infection and sepsis, which have emerged as the most prevalent and life-threatening complications significantly impacting prognosis. The etiological spectrum of organisms following LT has undergone substantial changes over recent decades. This retrospective monocentric study included a consecutive cohort of 776 LT patients from 2010 to 2023. A total of 207 pathogens were isolated from 180 infection sites of 156 (20.1%) patients, comprising 82 (39.6%) gram-positive bacteria, 90 (43.5%) gram-negative bacteria, and 35 (16.9%) fungi. Among the gram-negative bacteria, carbapenem-resistant Enterobacteriaceae (CRE) was found in eight cases (seven Klebsiella pneumoniae and one Escherichia coli), extended-spectrum beta-lactamases (ESBLs)-producing bacteria were detected in seven cases (five Escherichia coli and two Enterobacter cloacae), and carbapenem-resistant Acinetobacter baumannii (CRAB) was found in 14 cases and 2 cases had carbapenem-resistant Pseudomonas aeruginosa (CRPA). Advanced age, prolonged mechanical ventilation, and extended ICU stay were significantly associated with increased susceptibility to post-LT infections. Infected patients with bilirubin levels exceeding 90 µmol/L (OR 3.46, 95% CI 1.46-8.24; P = 0.005) as well as drug-resistant bacterial infections (OR 2.35, 95% CI 1.07-5.15; P = 0.033) were more likely to develop sepsis. More than 45% of bacterial infections were caused by drug-resistant pathogens, with over 30% of gram-negative bacteria exhibiting carbapenem resistance. In conclusion, the implementation of strategies aimed at reducing the duration of mechanical ventilation and ICU stay may effectively decrease the incidence of post-liver transplantation infection. Furthermore, pre-transplant interventions targeting reduction in jaundice could potentially mitigate the risk of post-transplant sepsis.IMPORTANCEThis study elucidates the recent pathogen spectrum associated with infections in liver transplantation and compares it with the pathogen spectrum from previous periods. Additionally, it analyzes high-risk factors for post-transplant infections and innovatively examines the risk factors that contribute to the progression from infection to severe infection and sepsis. Based on these findings, potential intervention strategies targeting infection and sepsis are proposed.